Search results

Order by most recent / most popular / relevance

Results: 1-6 of 6

Pom’s battle for truth, justice, and the pomegranate way

Arent Fox LLP
-
USA
-
October 12 2010

Pom Wonderful has added another suit to its already busy docket

Maine repeals laws mandating price, marketing cost, and clinical trial reporting by pharmaceutical manufacturers

Arent Fox LLP
-
USA
-
August 26 2011

On July 8, 2011, Governor Paul LePage of Maine signed into law LD 719 titled “An Act to Make Certain Prescription Drug Disclosure Laws Consistent with Federal Law”

Proposed rule published requiring special packaging for drugs containing imidazolines

Arent Fox LLP
-
USA
-
February 8 2012

On January 25, 2012, CPSC published a Proposed Rule in the Federal Register requiring use of child-resistant packaging for any over-the-counter (OTC) or prescription drug containing 0.08 milligrams or more of an imidazoline in a single package

Warning Letter to Lancôme signals stepped-up enforcement of cosmeticscosmeceuticals

Arent Fox LLP
-
USA
-
September 11 2012

On September 7, 2012, the U.S. Food and Drug Administration (FDA) issued a Warning Letter to high-end cosmetics maker, Lancôme USA, due to product claims on the company’s website

First Amendment protects off-label promotional speech, Second Circuit holds

Arent Fox LLP
-
USA
-
December 6 2012

In a highly significant and long-awaited ruling, the United States Court of Appeals for the Second Circuit has overturned the conviction of a pharmaceutical sales representative for promoting his company’s products for uses not approved by the Food and Drug Administration

FDAFTC issue joint Warning Letter for cold & flu product

Arent Fox LLP
-
USA
-
January 31 2013

The FDA and FTC issued a rare multi-agency Warning Letter to Flu and Cold Defense LLC (FCD) on January 24, 2013 for claiming that its product

Search results

Pom’s battle for truth, justice, and the pomegranate way

Maine repeals laws mandating price, marketing cost, and clinical trial reporting by pharmaceutical manufacturers

Proposed rule published requiring special packaging for drugs containing imidazolines

Warning Letter to Lancôme signals stepped-up enforcement of cosmeticscosmeceuticals

First Amendment protects off-label promotional speech, Second Circuit holds

FDAFTC issue joint Warning Letter for cold & flu product

Current Search

Suggested Facets

Author

Workarea